Awake craniotomy for brain tumor resection has emerged as a paradigm shift in neurosurgical oncology, allowing maximal tumor removal while preserving critical neurological functions. The present review examines current anesthesiologic concepts in awake brain tumor surgery, emphasizing the role of the anesthesiologist in patient selection, perioperative management, and neurological monitoring. A comprehensive literature search (2015–2025) was conducted to identify advances in anesthetic techniques, sedation strategies, and pain and complication management in awake craniotomy. Key factors such as meticulous patient selection, advanced anesthetic and analgesic techniques, intraoperative brain mapping, and multidisciplinary planning are highlighted. Awake craniotomy can achieve extensive tumor resection with reduced neurological deficits by enabling real-time functional testing during surgery. The anesthesiologist's expertise in maintaining patient comfort, airway control, hemodynamic stability, and rapid intervention for events like seizures is crucial. Modern approaches, including regional anesthesia, conscious sedation with agents like dexmedetomidine, and multimodal pain management, have improved patient tolerance and outcomes. By integrating careful preoperative planning, sophisticated intraoperative monitoring, and proactive postoperative care, awake brain tumor surgery can be performed safely and effectively.
Introduction. Traumatic brain injury affects over 50 million people worldwide annually, with mild traumatic brain injury accounting for approximately 80%. The number of elderly patients sustaining such injuries is increasing. This study aimed to compare differences in consciousness impairment and computed tomography findings among mild traumatic brain injury patients of different age groups upon hospital admission. Material and Methods. This retrospective study included 150 patients with mild traumatic brain injury hospitalized at the Neurosurgery Clinic of the Clinical Center of Vojvodina between January 1, 2020 and July 1, 2021. Patients were categorized into three age groups and compared based on the level of consciousness impairment, assessed using the Glasgow Coma Scale, and computed tomography findings evaluated using the Rotterdam score. Results. Statistical analysis revealed that the mean Rotterdam score was 1.6 in patients aged 18-30 years, 1.64 in those aged 31-65 years, and 2.36 in patients over 65 years. The difference between the mean Rotterdam scores between the oldest group and other two groups was highly statistically significant. Conclusion. The findings indicate a significant correlation between age and injury severity, with older patients exhibiting more severe computed tomography findings. However, impairment of consciousness at admission remained comparable across all age groups.
14 October 2026 in Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery
To externally validate the 3-point Simplified Motor Score (SMS) against the 15-point Glasgow Coma Scale (GCS) for predicting outcomes after traumatic brain injury (TBI). Retrospective cohort of consecutive adult patients with TBI evaluated at the Department of Neurosurgery, University Clinical Centre of Vojvodina, Serbia, in 2017. Discrimination for in-hospital mortality, emergency intubation, and non-home discharge was assessed using the area under the receiver operating characteristics (ROC) curve (AUC), with pairwise comparisons by the DeLong test. Agreement was quantified by Cohen's κ. Of 823 patients, with a median age of 58 years, 66.1% were male, 7.7% died, 9.7% required emergency intubation, and 16.5% had non-home discharge. The AUCs for GCS and SMS were 0.882 versus 0.837 for mortality; 0.967 versus 0.927 for intubation; and 0.835 versus 0.762 for non-home discharge respectively. The AUC differences between GCS and SMS ranged from 0.040 to 0.072. Agreement between SMS ≤ 1 and GCS ≤ 13 was high (κ = 0.84). The GCS was more accurate in patients aged ≥ 65 years. The SMS preserved most of the discriminative ability of the full GCS for acute outcomes but underperformed for disposition outcomes and in older patients. The SMS is best used as a rapid bedside complement to the GCS.